GRIFFITH MELINDA 4
4 · Oncocyte Corp · Filed Aug 17, 2022
Insider Transaction Report
Form 4
GRIFFITH MELINDA
Director
Transactions
- Purchase
Common Stock, no par value
2022-08-16$1.00/sh+10,000$10,000→ 30,000 total - Award
Common Stock, no par value
2022-08-15+10,000→ 20,000 total - Award
Option to Purchase Common Stock
2022-08-15+45,000→ 45,000 totalExercise: $0.97Exp: 2032-08-15→ Common Stock (45,000 underlying)
Footnotes (2)
- [F1]The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.
- [F2]Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.